Dr. William Makis, onkologur, serlækni í krabbameinssjúkum, - hevur sjúkugreinað omanfyri 20.000 krabbameinssjúklingar

Kanadiski Dr. William Makis lýsir her framúr góðu eginleikarnir Ivermectin hevur, sum týðandi amboð í krabbameinsviðgerð.

mRNA íleguviðgerðin er vorin orsók til ógvusligan vøkstur í krabbamens-títtleika, har "turbo krabbi" ger um seg, og er torført at viðgerða hendan, tá vanligu viðgerðarhættirnir aloftast ikki rína við.

Dr. Dueñas-González’s research

Different from many conventional cancer therapies, Ivermectin kills cancer cells by enhancing immune response.

Ivermectin has shown some degree of anti-cancer effect in every cancer type it has been tested on, oncologist Dr. Ruddy said.

Dr. Dueñas-González’s research has shown that at least 26 different cancer cell lines, including prostate, kidney, esophageal, breast, ovarian, lungs, glioblastoma, stomach, colon, liver, lymphoma, uterus, pancreas, and bladder, respond to Ivermectin in laboratory studies.

Dr. John Campbell tosar við Prof. Angus Dalgleish um krabbameinsviðgerð

Ivermectin, Thalidomide og vitamin D

Koppingarevnið IMM-101

Tað er staðfest at vera av størsta týdningi at D-vitamin støðið er stimbrað í topp áðrenn krabbameinsviðgerðin byrjar. Kemoterapi eydnast ikki er D-vitamin støðið í botni, sum annars er vanligt um okkara leiðir, tá sólin er so kørg, og D-vitamin støðið annars byrjar at fella um 55 ára aldur, røkja vit ikki D-vitamin støðið.

IVERMECTIN hevur fleiri enn 15 eginleikar at berja niður krabba.

Hevur Ivermectin eginleikar at taka hond um turbokrabba, sum stavar frá COVID-19 mRNA-koppingarevninum? Her verða 9 Ivermectin frágreiðingar lýstar.                                                   

Dr. Makis lýsir her hvørjar royndir eru gjørdar við Ivermectin viðgerð, og hvussu farast skal fram.                                                       

IVERMECTIN & MEBENDAZOLE Testimonial:

Stage 3A Ovarian Adenocarcinoma - CA125 cancer marker drop by 30% in just 3 weeks of high dose regimen

MEBENDAZOLE and LEUKEMIA - potent inhibitor of T-cell ALL Leukemia cells and overcomes chemoresistance! Rare 2020 study shows Mebendazole out-performs chemo

MEBENDAZOLE and Thyroid Cancer - Inhibits tumor growth and prevents lung metastasis - shocking new Johns Hopkins research on Fenbendazole's sister drug

MEBENDAZOLE kills Ovarian Cancer Cells that are resistant to Chemotherapy. Once again, a cheap anti-parasitic outperforms a

$500 million key chemotherapy agent.

I find it fascinating that there is a “repurposed drug” that you can buy for $2 a pill from a pharmacy in India, that outperforms the main treatment for Ovarian Cancer, which itself is a $500 million a year drug

Mebendazole and Triple Negative Breast Cancer brain metastases - Mebendazole selectively targets migrating tumor cells according to

2024 paper by Stanford authors.

Pfizer and Moderna COVID-19 mRNA Vaccines complicate the picture because they cause Turbo Cancer, and in the top 3 most common Turbo Cancers are Breast cancers, vast majority of which are Triple Negative.

Mebendazole, Fenbendazole and Albendazole in Osteosarcoma - Mebendazole superior in multiple anti-cancer pathways.

The danger I currently see, is COVID-19 mRNA Vaccinated children coming down with SARCOMAS. These are extremely aggressive and difficult to treat. And at this time, no one wants to talk about it.

Mebendazole preferred to Fenbendazole in treatment of Glioblastoma Brain Cancer - and a story of how Fenbendazole was accidentally discovered to have anti-cancer properties.

So for Glioblastoma, it’s Mebendazole if you can get it. Otherwise, get Fenbendazole.

FENBENDAZOLE and MEBENDAZOLE in the treatment of Multiple Myeloma.

For Multiple Myeloma, Mebendazole shows advantage over Fenbendazole at every dose.

Mebendazole’s ability to kill Multiple Myeloma cells, is very impressive.

FENBENDAZOLE vs MEBENDAZOLE in Pancreatic Cancer, Colon Cancer and Paragangliomas - which repurposed anti-parasitic Drug is better?

Both increase p53 tumor suppressor levels, which are impaired in 50-60% of all cancers and even further impaired in those who took COVID-19 mRNA Vaccines and developed TURBO CANCER.

This time, Fenbendazole takes the crown for three cancers: Pancreatic, Colorectal and Paragangliomas.

FENBENDAZOLE vs MEBENDAZOLE in Pancreatic Cancer - which is better? Obscure Italian study gives the answer in the battle of the anti-parasitics.

For a cancer patient, what’s most important is availability and access to these drugs.

If you have access to both, Fenbendazole kills pancreatic cells mildly better than Mebendazole.

NEW PODCAST! "15 minutes with Dr.Makis" - Episode 020: MEBENDAZOLE and CANCER.

FDA Approved "version" of FENBENDAZOLE Promising new therapy for COVID-19 mRNA Vaccine Turbo Cancer: Lymphoma, leukemia, breast TNBC, colon, lung, melanoma (increases p53).

FENBENDAZOLE and CANCER Part 2 - Treating Turbo Cancer - 10 new studies released in 2023-2024 (also Mebendazole) - suggested PROTOCOLS for COVID-19 mRNA Vaccine Induced Turbo Cancers.

There is still some research being done on Fenbendazole & Cancer, but researchers are focusing more on other related compounds in the “Benzimidazole family”, namely Mebendazole, but also Albendazole, Parbendazole. Why?

The cost:

Fenbendazole is cheap. If big pharma is going to make money (especially in cancer treatment), they need an expensive compound and Fenbendazole isn’t it.

Fenbendazole is not FDA approved. It’s dirt cheap       FENBENDAZOLE

Mebendazole is FDA approved. It’s expensive              MEBENDAZOLE

Albendazole is FDA approved.                                      It’s very expensive 

NEWS: Pancreatic Cancer patient survival doubled with high dose of common vitamin (Vitamin C IV Infusions), study finds